-
1
-
-
0036311162
-
Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction
-
DOI 10.1016/S0002-9270(02)04177-1
-
Miller L. S., Pullela S. V., Parkman H. P. et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastro (Pubitemid 34761383)
-
(2002)
American Journal of Gastroenterology
, vol.97
, Issue.7
, pp. 1640-1646
-
-
Miller, L.S.1
Pullela, S.V.2
Parkman, H.P.3
Schiano, T.D.4
Cassidy, M.J.5
Cohen, S.6
Fisher, R.S.7
-
2
-
-
0035653739
-
Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: A prospective study with long-term follow-up
-
DOI 10.1067/mge.2001.119256
-
Storr M., Allescher H. D., Rosch T. et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc: 2001; 54 754 759 (Pubitemid 33668684)
-
(2001)
Gastrointestinal Endoscopy
, vol.54
, Issue.6
, pp. 754-759
-
-
Storr, M.1
Allescher, H.-D.2
Rosch, T.3
Born, P.4
Weigert, N.5
Classen, M.6
-
3
-
-
84882793667
-
Botulinum toxin reduces dysphagia in patients with non-achalasia primary esophageal motility disorders
-
Vanuytsel T., Bisschops R., Farre R. et al. Botulinum toxin reduces dysphagia in patients with non-achalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol: 2013; 11 1115 1121
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 1115-1121
-
-
Vanuytsel, T.1
Bisschops, R.2
Farre, R.3
-
4
-
-
84855917246
-
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography
-
01
-
Bredenoord A. J., Fox M., Kahrilas P. J. et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil: 2012; 24 01 57 65
-
(2012)
Neurogastroenterol Motil
, vol.24
, pp. 57-65
-
-
Bredenoord, A.J.1
Fox, M.2
Kahrilas, P.J.3
-
5
-
-
3242670022
-
Safety of botulinum toxin type A: A systematic review and meta-analysis
-
DOI 10.1185/030079904125003962
-
Naumann M., Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin: 2004; 20 981 990 (Pubitemid 38954460)
-
(2004)
Current Medical Research and Opinion
, vol.20
, Issue.7
, pp. 981-990
-
-
Naumann, M.1
Jankovic, J.2
-
6
-
-
35448958806
-
A case of mediastinitis following botulinum toxin type A treatment for achalasia
-
MacIver R., Liptay M., Johnson Y. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol: 2007; 4 579 582
-
(2007)
Nat Clin Pract Gastroenterol Hepatol
, vol.4
, pp. 579-582
-
-
Maciver, R.1
Liptay, M.2
Johnson, Y.3
-
7
-
-
0030949772
-
Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia
-
Eaker E. Y., Gordon J. M., Vogel S. B. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci: 1997; 42 724 727 (Pubitemid 27196020)
-
(1997)
Digestive Diseases and Sciences
, vol.42
, Issue.4
, pp. 724-727
-
-
Eaker, E.Y.1
Gordon, J.M.2
Vogel, S.B.3
-
8
-
-
77952877241
-
Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia
-
Radaelli F., Paggi S., Terreni N. et al. Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia. Gastrointest Endosc: 2010; 71 1326 1327
-
(2010)
Gastrointest Endosc
, vol.71
, pp. 1326-1327
-
-
Radaelli, F.1
Paggi, S.2
Terreni, N.3
|